RARE AND NEW MUTATIONS OF B-GLOBIN IN AZARI POPULATION OF IRAN, A CONSIDERABLE DIVERSITY

被引:3
作者
Abbasali, F. H. [3 ]
Mahmoud, K. Sh. [4 ]
Hengameh, N.
Mina, D. H.
Setare, D.
Hale, D. M.
Sima, D. M. [1 ,2 ,4 ]
机构
[1] Tabriz Univ Med Sci, Fac Med, Dept Med Genet, Tabriz, Iran
[2] Tabriz Univ Med Sci, Specialized & Subspecialized Outpatient Clin, Ebne Sina Med Genet Lab, Tabriz, Iran
[3] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Fac Med, Med Genet Dept, Tabriz, Iran
关键词
Azeri Turkish Population; beta-globin; Rare; Mutations; Iran; BETA-THALASSEMIA; MOLECULAR CHARACTERIZATION; GENE; PREVALENCE; VARIANTS; CITY; HOPE;
D O I
10.2478/bjmg-2022-0016
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Thalassemia, as the most common single-gene genetic disorder, is related to a defect in the synthesis of one or more hemoglobin chains. More than 200 mutations have been identified in the beta-globin gene. Globally, every susceptible racial group has its own specific spectrum of the common mutations that are well-known to a particular geographic region. On the other hand, varying numbers of diverse rare mutations may occur. Materials and Methods The subjects of the study included 2113 heterozygote or homozygote beta-thalassemia cases selected among couples who participated in the Iranian national thalassemia screening program from January 2011 to November 2019. Molecular characterization of the beta-thalassemia mutation was initially carried out by the amplification-refractory mutation system-polymerase chain reaction (ARMS-PCR) technique for common mutations, followed by sequencing, Gap PCR, and Multiple ligation-dependent probe amplification (MLPA) methods - in cases not detected by the ARMS-PCR. Results The existence of 39 rare and new point mutations and 4 large deletions were described in our cohort. Sicilian (-13,337bp) deletion, CD36/37 (-T), and CD15 TGG>TGA were encountered more often than the others in a decreasing order, in terms of frequency. The least frequent mutations/deletions were deletion from HBD exon 1 to HBB promoter, 619 bp deletion, Deletion from up HBBP1Exon3 HBBP1 and up HBB-0.5Kb down HBB, CAP+8 C>A, CD37 (G>A), CD6 (-A), IVSI-2 (T>C), IVSII-705 T>G, and IVSII-772 (G>A). Each occurred once. Five mutations/variants were also determined which have not been reported previously in Iran. Conclusion According to the findings of the study, the Northwestern Iranian population displayed a wide variety of thalassemia allelic distributions. Identification of rare and new mutations in the beta-thalassemia in the national population is beneficial for screening programs, genetic counseling, and prenatal diagnosis
引用
收藏
页码:51 / 62
页数:12
相关论文
共 49 条
[31]   A SILENT HEMOGLOBIN-VARIANT DETECTED BY HPLC - HEMOGLOBIN CITY-OF-HOPE BETA-69(E13)GLY-]SER [J].
RAHBAR, S ;
ASMEROM, Y ;
BLUME, KG .
HEMOGLOBIN, 1984, 8 (04) :333-342
[32]   β-globin gene cluster haplotypes in sickle cell patients from southwest Iran [J].
Rahimi, Z ;
Karimi, M ;
Haghshenass, M ;
Merat, A .
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 74 (03) :156-160
[33]   Beta-Thalassemia in Iran: New Insight into the Role of Genetic Admixture and Migration [J].
Rezaee, Ali Reza ;
Banoei, Mohammad Mehdi ;
Khalili, Elham ;
Houshmand, Massoud .
SCIENTIFIC WORLD JOURNAL, 2012,
[34]  
Roudknar M. H., 2003, IRAN J PUBLIC HEALTH, P11
[35]  
Roudknar M. H., 2003, IRAN J PUBLIC HEALTH, V32, P11
[36]   Iranian national thalassaemia screening programme [J].
Samavat, A ;
Modell, B .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7475) :1134-1137
[37]  
Sarookhani MR, 2010, AFR J BIOTECHNOL, V9, P95
[38]   HAEMOGLOBIN GCOPENHAGEN AND HAEMOGLOBIN JCAMBRIDGE . 2 NEW BETA-CHAIN VARIANTS OF HAEMOGLOBIN A [J].
SICK, K ;
BEALE, D ;
IRVINE, D ;
LEHMANN, H ;
GOODALL, PT ;
MACDOUGALL, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 140 (02) :231-+
[39]  
Sima Mansoori Derakhshan A. K., 2015, EPIDEMIOLOGY OPEN AC, V5
[40]   Thalassaemia [J].
Taher, Ali T. ;
Weatherall, David J. ;
Cappellini, Maria Domenica .
LANCET, 2018, 391 (10116) :155-167